ArmonAir® Digihaler™ (fluticasone propionate) – New formulation approval
February 24, 2020 - Teva announced the FDA approval of ArmonAir Digihaler (fluticasone propionate) inhalation powder, for the maintenance treatment of asthma as prophylactic therapy in patients 12 years of age and older.
Download PDF
